Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Omnicell Q2 Adj $0.51 Beats $0.14 Estimate, Sales $276.79M Beat $255.20M Estimate

Author: Benzinga Newsdesk | August 01, 2024 07:12am
Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.14 by 264.29 percent. This is a 10.53 percent decrease over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $276.79 million which beat the analyst consensus estimate of $255.20 million by 8.46 percent. This is a 7.42 percent decrease over sales of $298.97 million the same period last year.

Posted In: OMCL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist